Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Z Błoński

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1994
[Antitumor immunotherapy]J Z Błoński, K Warzocha
Leukemia & Lymphoma|May 30, 2001
Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?T Robak, J Z Błoński, M Kasznicki
Leukemia & Lymphoma|June 1, 1999
2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemiaT Robak, M Błasińska-Morawiec, J Z Błoński, et al.
Neoplasma|November 30, 2002
Expression of gene encoding P65 oncofetal protein in acute and chronic leukemiasE Balcerczak, J Bartkowiak, J Z Błoński, et al.
Chemotherapy|August 10, 2005
Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignanciesT Robak, A Szmigielska-Kapłon, J Z Błoński, et al.
Mediators of Inflammation|May 18, 2000
Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remissionT Robak, A Wierzbowska, M Błasińska-Morawiec, et al.
Leukemia & Lymphoma|May 30, 2001
Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosusT Robak, E Robak, J Bartkowiak, et al.
Cytobios|November 22, 2000
Some oncogene and tumour suppressor gene protein products expression in B-cell chronic lymphocytic leukaemiaH Niewiadomska, M Mirowski, D Kulczycka, et al.
European Journal of Haematology|May 15, 2001
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesT Robak, J Góra-Tybor, E Lech-Marańda, et al.
Leukemia|April 24, 1999
2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and youngerT Robak, J Z Błoński, H Urbańska-Ryś, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1994
[Antitumor immunotherapy]J Z Błoński, K Warzocha
Leukemia & Lymphoma|May 30, 2001
Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?T Robak, J Z Błoński, M Kasznicki
Leukemia & Lymphoma|June 1, 1999
2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemiaT Robak, M Błasińska-Morawiec, J Z Błoński, et al.
Neoplasma|November 30, 2002
Expression of gene encoding P65 oncofetal protein in acute and chronic leukemiasE Balcerczak, J Bartkowiak, J Z Błoński, et al.
Chemotherapy|August 10, 2005
Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignanciesT Robak, A Szmigielska-Kapłon, J Z Błoński, et al.
Mediators of Inflammation|May 18, 2000
Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remissionT Robak, A Wierzbowska, M Błasińska-Morawiec, et al.
Leukemia & Lymphoma|May 30, 2001
Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosusT Robak, E Robak, J Bartkowiak, et al.
Cytobios|November 22, 2000
Some oncogene and tumour suppressor gene protein products expression in B-cell chronic lymphocytic leukaemiaH Niewiadomska, M Mirowski, D Kulczycka, et al.
European Journal of Haematology|May 15, 2001
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesT Robak, J Góra-Tybor, E Lech-Marańda, et al.
Leukemia|April 24, 1999
2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and youngerT Robak, J Z Błoński, H Urbańska-Ryś, et al.
Pageof 2